NASDAQ:BLGO BioLargo (BLGO) Stock Price, News & Analysis $0.17 0.00 (-1.24%) As of 08/8/2025 03:38 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About BioLargo Stock (NASDAQ:BLGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioLargo alerts:Sign Up Key Stats Today's Range$0.17▼$0.1850-Day Range$0.17▼$0.2252-Week Range$0.16▼$0.32Volume364,136 shsAverage Volume314,548 shsMarket Capitalization$51.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California. Read More Receive BLGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. Email Address BLGO Stock News HeadlinesBioLargo Highlights 2025 Progress and Future OutlookJuly 23, 2025 | tipranks.comBioLargo initiates alpha testing of Verralize’s portable PFAS test kitJuly 2, 2025 | finance.yahoo.comBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. | Crypto 101 Media (Ad)Independent Evaluation Confirms Breakthrough Performance of BioLargo’s Cellinity Battery Technology for Grid-Scale Energy StorageJune 18, 2025 | usatoday.comEarnings call transcript: BioLargo Q1 2025 revenue misses forecast, stock dipsMay 17, 2025 | investing.comBioLargo Inc (BLGO) Q1 2025 Earnings Call Highlights: Strategic Innovations Amid Financial ...May 16, 2025 | finance.yahoo.comBioLargo, Inc: BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent TechnologiesMay 5, 2025 | finanznachrichten.deEarnings call transcript: BioLargo Q1 2025 reveals strong revenue growthApril 2, 2025 | investing.comSee More Headlines BLGO Stock Analysis - Frequently Asked Questions How have BLGO shares performed this year? BioLargo's stock was trading at $0.19 at the beginning of the year. Since then, BLGO shares have decreased by 11.6% and is now trading at $0.1679. How do I buy shares of BioLargo? Shares of BLGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLargo own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLargo investors own include Hydrofarm Holdings Group (HYFM), Avino Silver & Gold Mines (ASM), Meta Platforms (META), Micron Technology (MU), Petroleo Brasileiro S.A.- Petrobras (PBR), Clean Energy Fuels (CLNE) and FuelCell Energy (FCEL). Company Calendar Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConstruction Industry Chemicals & allied products Sub-IndustryChemicals Current SymbolNASDAQ:BLGO CIK880242 Webwww.biolargo.com Phone(888) 400-2863Fax949-625-9819Employees30Year Founded1989Profitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.50 million Net Margins-11.45% Pretax Margin-19.65% Return on Equity-39.90% Return on Assets-22.06% Debt Debt-to-Equity Ratio0.03 Current Ratio2.31 Quick Ratio2.24 Sales & Book Value Annual Sales$12.23 million Price / Sales4.22 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book16.79Miscellaneous Outstanding Shares307,300,000Free Float240,168,000Market Cap$51.60 million OptionableNot Optionable Beta0.05 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:BLGO) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFOUR TRILLION DOLLARS!Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.